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Drug and alcohol dependence are associated with enhanced attention for drug-related stimuli. This cognitive processing bias has been
suggested to be related to craving and to represent one of the core mechanisms of addition. The present study tests the hypothesis that
enhanced attention for heroin cues is mediated by the dopaminergic system using haloperidol as dopamine antagonist. In a double blind,
randomized crossover design, 17 detoxified heroin dependent patients received a single oral dose of haloperidol 2 mg and placebo. Patients
performed an Emotional Stroop Task to assess the cognitive processing of drug cues under both conditions. In addition, self-reported craving
was assessed. In the haloperidol condition, patients performed better on the Emotional Stroop Task than in the placebo condition. However,
no effect of haloperidol on subjective craving was found. These findings provide preliminary indications that attentional bias in heroin
dependent humans is mediated by dopaminergic mechanisms.
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Recent studies provide evidence that drug dependent
subjects exhibit an excessive attentional focus on drug-
related cues (for a review see Franken, 2003). This atten-
tional bias, which has been found to be present in alcohol
(Johnsen et al., 1994), heroin (Franken et al., 2000; Lubman
et al., 2000), and nicotine dependence (Ehrman et al., 2002;
Waters and Feyerabend, 2000), may promote craving and
ultimately relapse (Cox et al., 2002; Waters et al., 2003b).
Recently, theoretical accounts have been developed that
posit enhanced attentional processing of motivational rele-
vant cues is the ‘core process’ of addiction (Robinson and
Berridge, 1993). Although the presence of this attentional
bias in heroin addiction has been adequately demonstrated
using behavioral (Franken et al., 2000) and neurophysiolog-
ical measures (Franken et al., 2003; Franken et al., in press),0924-977X/$ - see front matter D 2004 Elsevier B.V. and ECNP. All rights reser
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is scarce. Recently, advances have been made in knowledge
on the neural basis of these processing biases (Elliott et al.,
2002). These authors found that the medial and orbital
prefrontal regions play a role in mediating the interaction
between mood and cognition in affective disorder. However,
the psychopharmacology of processing biases has not been
studied before. It has been suggested that the dopamine
signal serves to draw attention to salient events in general
(Gray et al., 1997). In a review, Schultz (1998) shows that the
processing of appetitive stimuli in animals is dopaminergi-
cally regulated. More specifically, Robinson and Berridge
(1993) hypothesize that activation of dopaminergic activity
in the cortico-striatal reward circuit by cues which signal
reward could contribute to the excessive focusing on stimuli,
which lead to further drug use. Although there is some
evidence for this hypothesis in animal studies (see e.g. Ito
et al., 2000, 2002; Phillips et al., 2003), human studies
investigating the role of dopamine in drug-related cognitions
are not known. One of the basic assumptions of Schultz and
the Robinson and Berridge Incentive-sensitization model,
that the role of dopaminergic neurotransmission is to directved.
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the present study. Based on the Incentive-sensitization mod-
el, Franken (2003) hypothesized that cue-elicited dopamine
release is directly related to an enhanced attentional bias for
drug cues in abstinent heroin users.
In the present study, this hypothesis will be tested by a
dopamine antagonist challenge. The hypothesized excessive
dopamine release will, at least partly, be prevented by a
single dose of a typical dopamine antagonist, haloperidol 2
mg. In a double blind randomized crossover design, 17
detoxified heroin dependent patients received a single oral
dose of haloperidol 2 mg and placebo. Patients performed
an Emotional Stroop Task under both conditions, and self-
reported craving was assessed. In previous studies haloper-
idol (4 mg) has been used successfully in decreasing cue-
elicited cocaine craving (Berger et al., 1996). Because this 4
mg dose may result in drowsiness, which may distort subtle
attentional processes, and to minimize the occurrence of
extrapyramidal side-effects, we chose for a single dose of 2
mg haloperidol. This dose has been successfully used in
modifying higher cognitive functions (Peretti et al., 1997).
Specifically, it has been found that 2 mg haloperidol is a
sufficient dose to induce modulation in selective and invol-
untary attention (Ahveninen et al., 2000; Kahkonen et al.,
2001). Nordstrom et al. (1992) demonstrated that D2
receptor occupancy 3 h after oral administration of a single
dose of 2 mg haloperidol was 18% and 52% after 6 h. In the
present study, 4 h were between admission and testing
which, according to the Nordstrom study, should result in
an about 30% D2 receptor occupancy.Table 1
Drug use characteristics of the heroin dependent group (n= 17)
MeanF S.D.
Age of first heroin use
(>3 times a week) (n= 17)
22.6F 7.0
Age of first cocaine use
(>3 times a week) (n= 17)
20.8F 5.6
Age of first methadone use
(>3 times a week) (n= 12)
24.8F 5.3
Total years of heroin use (n= 17) 8.8F 6.7
Total years of cocaine use (n= 17) 10.4F 6.3
Total years of methadone use (n= 12) 4.6F 6.4
Number of days of heroin use in
month before detoxification (n= 17)
26.7F 8.6
Number of days of cocaine use in
month before detoxification (n= 17)
25.8F 8.5
Number of days of methadone use in
month before detoxification (n= 12)
14.0F 12.82. Methods
2.1. Subjects
Eighteen eligible male heroin dependent subjects were
recruited from a detoxification unit of a substance abuse
program (Parnassia Mental Health Care). One subject was
excluded because a different Stroop Task was used; the
results of 17 patients were analyzed. All participants had
been abstaining from illicit drug use (including heroin and
cocaine) for a minimum of 2 weeks. None of the subjects
were positive on urine drug tests, which are employed
routinely in the detoxification unit. At the time of testing
none of the subjects was taking prescribed or non-prescribed
medications other than the research medication. Candidates
were excluded from the study if one of the following
conditions was present: withdrawal symptoms, lifetime use
of neuroleptic medication, schizophrenia, affective disorder,
mental retardation, significant somatic disorders such as
Parkinson disease (or symptoms). All subjects were male in
order to rule out gender effects. Of the subjects, six had lower
education, nine had middle education, and three had higher
education (according to the Dutch educational system). The
mean age of the sample was 35.7 years (S.D. = 6.4), which istypical for heroin users in treatment settings in the Nether-
lands (Ouwehand et al., 1999). Drug use characteristics are
displayed in Table 1. Most heroin dependent subjects (n = 17)
had a history of additional cocaine use and most subjects had
ever been in a methadone maintenance program (n = 12). The
study was approved by the Ethical Committee of the institu-
tion in which the work was performed.
2.2. Stimuli
Neutral and heroin words were presented in random
order. The Stroop Tasks consisted of 10 heroin-related
words (such as dope and heroin) and 10 neutral, transport-
related words (such as train and bike). For complete word
list and selection criteria of the words is referred to Franken
et al. (2000). The two categories of words were matched for
the number of letters and syllables (in Dutch). Each word
was presented in four times in a different color (red, yellow,
blue, green) in a random order resulting in 40 neutral and 40
heroin words in total.
2.3. Apparatus
All stimulus material was presented on an IBM G50
monitor, controlled by an IBM P-100 PC that also registered
the manual responses. The presentation of the stimuli was
programmed in ERTS language (Beringer, 1994). A stimu-
lus word in one of the four colors was presented on the
screen and remained on the screen until responding (max-
imum 3000 ms). The order of presentation was random,
with the restriction that a specific word category was not
presented more than four consecutive times. The inter-trial
interval was set at 1000 ms.
2.4. Self-report instruments
Instant craving was measured by the 14-item desire for
drug questionnaire (DDQ) (Franken et al., 2002). This
Fig. 1. Mean responding times (in ms) on neutral (white bars) and heroin
words (gray bars) by medication condition (n= 17), including error bars.
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questionnaire (DAQ) (Love et al., 1998) for use in heroin
addicts. It measures instant (now) craving and consists of
three subscales. The three subscales are: desire and intention
to use drugs, negative reinforcement (the relief of negative
states), and perceived control over drug-use. The three
subscales have good reliability and concurrent validity
(Franken et al., 2002).
Drug use severity was assessed by means of the drug use
scale of the addiction severity index (ASI) (Hendriks et al.,
1989). Questions in this scale refer to the different types of
drugs used, the numbers of days used, and duration of use.
The 32 item version of the Profile of Mood States
(POMS, De Groot, 1992; McNair et al., 1992) questionnaire
was used in order to investigate changes in mood states.
This version of the POMS consists of five subscales labeled
depression, anxiety, tension, vigor, and fatigue.
Subjectively experienced physiological symptoms were
investigated using the physiological symptoms question-
naire (PSQ, Powell et al., 1992). This scale contains a
three-item subscale on drug-positive symptoms (pleasant
feeling in stomach, itchy nose and feeling high) and a seven-
item subscale on drug negative symptoms (feeling cold,
runny nose, muscular tension, aches, gooseflesh, yawning
restlessness). Each item is scored on a four-point scale.
2.5. Procedure
Eligible subjects were asked to participate in a study
concerning the attentive processing of heroin words. They
were informed that participation involved the intake of 2 mg
haloperidol, conducting a reaction time task with heroin
words, and craving measurements. The participants received
a remuneration of 50 euro. All subjects provided written
informed consent. The experiment started with a short
explanation of the procedure and informed consent was
obtained. Personal data and history of drug use (ASI) were
recorded by the experimenter. Then the subject completed
the pre-exposure questionnaires. Subjects were sitting at a
table, approximately, 80 cm from the monitor. Instructions
were to attend to the color of the words and to ignore the
content. Furthermore, they were instructed to press the
corresponding colored button as quick as possible, without
making mistakes. In both sessions, a practice trial of 80
colored words (the word ‘‘test’’) was run first in order to get
used to the buttons. Then the emotional Stroop Task was
started. After having completed the two sessions, subjects
received their financial compensation and there was a check
by the experiment-leader whether the craving levels were
not unacceptable high. If so, a cool-down-talk was provided
until craving levels were decreased to an acceptable level.
2.6. Data analysis
In an attempt to reduce the influence of outliers, given
the high likelihood that these were artifacts, and to correctfor skewness, trials with response time (RT’s) more than 3
S.D. above and below the individual mean RT for each
condition were excluded for all analyses (3.1% of all trials).
Cutoff criterion of 3 S.D.’s from the mean has been a
common and robust method in eliminating outliers from
RT data (Ratcliff, 1993). RTs were averaged within each
Word type condition for each subject. RTs were analyzed
using a 2 (Word Type) 2 (Condition) repeated measure-
ments ANOVA. Results from the Mauchly Sphericity test
indicated that the assumption of sphericity was not violated.
Pairwise comparisons were made using ordinary t-tests. In
addition, error rates were also analyzed with a 2 (Word
Type) 2 (Condition) repeated measurements ANOVA.
Differences between the placebo and haloperidol-session
in self-reported craving, mood, and physical symptoms were
analyzed using a paired t-test.3. Results
3.1. Effects of haloperidol on cognitive processing
The mean RTs on the two word categories by condition
are displayed in Fig. 1. There was a main effect of
medication condition: RT’s in the haloperidol condition
were significantly faster than in the placebo condition,
F(1,16) = 5.18, P= 0.037. No significant main effect was
found for Word type, F(1,16) = 0.56, P= 0.466. In addition,
an interaction effect was observed, F(1,16) = 0.4.72,
P= 0.045. This indicates that individuals in the haloperidol
condition were faster to indicate word color of the heroin
words, thereby suggesting that, within a heroin dependent
Table 2
Mean (S.D.) values of self-reported craving, mood, and physical symptoms
after placebo and haloperidol, including t-values (n= 17)
Placebo Haloperidol t-value
DDQ desire 1.8 (1.3) 2.1 (1.1)  1.50
DDQ negative
reinforcement
craving
4.3 (2.2) 4.4 (2.0)  0.60
DDQ control 2.1 (1.7) 2.1 (1.5) 0.10
POMS depression 6.3 (5.3) 9.2 (7.0)  2.65*
POMS anxiety 7.1 (6.1) 7.7 (6.7)  0.56
POMS fatigue 8.5 (7.3) 10.5 (7.7)  1.12
POMS vigor 9.8 (4.3) 8.8 (4.7) 0.80
POMS tension 6.9 (4.8) 7.5 (4.5)  0.65
PSQ positive symptoms 1.4 (0.3) 1.4 (0.4)  0.21
PSQ negative symptoms 1.9 (0.6) 2.0 (0.8)  0.59
* P= 0.017; other values not significant at the 0.05 level.
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gestion of a dopamine antagonist.
Within the placebo session, the percentages of error rates
of neutral and heroin words were 1.7% and 3.8%, respec-
tively. Within the haloperidol-session, the percentages of
error rates of neutral and heroin words were 1.7% and 3.6%,
respectively. In the ANOVA for error rates, no significant
main or interaction effect could be observed, all Fs < 1.0.
3.2. Effects of haloperidol on self-reported craving, mood
and physical symptoms
Mean values of the DDQ, POMS and PSQ are displayed
in Table 2. The only significant effect on the self-reported
measures was the observation that patients reported more
depressive symptoms during the haloperidol-session com-
pared to the placebo session. In addition, in none of the
patients extrapyramidal side-effects, or other visible side-
effects could be observed.
3.3. Validity checks
Order effects were not significant. A 2 (session) 2 (word
type) ANOVA showed that, overall, subjects did not perform
different on the first versus second session, F(1,16) = 1.59,
P= 0.226. In addition, no sessionword type interaction
effect could be observed, F(1,16) = 0.107, P= 0.748.
In addition, patients were asked whether they believed
they received the first or the second day the active medica-
tion. Forty-one percent of the patients guessed correctly.
This guess is not different from the 50% chance level,
t(16) = 7.2, P= 0.48). Thus it may be concluded that the
conditions were indeed double blind.4. Discussion
The present study shows that attentional processes in
abstinent heroin dependent patients can be modified by alow dose of haloperidol. It can be speculated that abstinent
heroin abusers are less distracted by heroin words by this
low dose of haloperidol. The found significant interaction
effect provides a first indication to assume that a D2
dopamine antagonist decreases attentional focusing on drug
cues in humans.
Our finding provides indirect evidence for the assump-
tion that the perception of drug-related cues results in
increased in dopamine activity (Di Chiara, 1999; Robinson
and Berridge, 1993). The improvement on the general
selective attention with haloperidol in heroin users can be
interpreted as evidence that the dopamine levels were
increased during the Stroop Task with placebo. This finding
is in line with the sensitization theory, which claims that
enhancements of the incentive salience of drug-related cues,
which is present in drug dependent patients, is dopaminer-
gically mediated. Furthermore, it provides preliminary evi-
dence for the hypothesis that dopamine triggers the brain’s
attention towards motivational significant stimuli (Franken,
2003; Robinson and Berridge, 1993).
In addition to an interaction effect, overall selective
attention was also improved by haloperidol compared to
placebo. One explanation of this effect is that the heroin
words in the Stroop Task elicit a general distracting state and
a general focusing on heroin cues which results in increased
overall reaction times. For example, it is known that if drug-
related words are followed by neutral words, so-called
‘‘carry-over’’ effects appear which result in an increase in
RTs to neutral words (Waters et al., 2003a). This effect is
generally present in mixed randomized word sequences of
emotional Stroop Tasks (Waters et al., submitted for publi-
cation) and is specifically present in the heroin Stroop Task
that is used in this study (Franken et al., 2000; Waters et al.,
submitted for publication). This carry-over effect results
subsequently in a general increase in reaction times on the
task. Probably, this carry-over effect captures the difficulty
of disengaging attention from emotional salient stimuli such
as heroin (Waters et al., 2003a) and may therefore reflect an
incremental component of attentional bias (Waters et al.,
submitted for publication). The present findings show faster
reaction times during the haloperidol-session compared to
placebo, thereby suggesting that haloperidol attenuates this
difficulty of disengaging. In addition, the finding that
haloperidol improves overall attentional functioning in her-
oin dependent patients can be explained by the ability of
haloperidol to normalize a dopamine-induced disruption in
attention (Brockel and Fowler, 1995). It is known that both
increased or decreased dopamine activity results in disrup-
tion of attentional functions in healthy humans (Nieoullon,
2002; Shelley et al., 1997). In addition, normalizing the DA
transmission in patients with dopamine abnormalities will
result in improvements of cognitive functions (Nieoullon,
2002). In the present study, we observed a general improve-
ment on the Stoop task. This observation is in line with
studies on other psychiatric disorders in which an excessive
dopamine activity is present, such as schizophrenia. In
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provement of selective attention (Kumari et al., 1999).
We were not able to confirm the a priori hypothesis that
dopamine antagonist reduce cue-elicited craving. Further-
more, this finding not in accordance with the hypothesis that
attentional bias and craving are closely related to each other
(Franken, 2003). According this hypothesis, a decrease in
attentional bias should result in a decreased craving (and
vice versa). The finding that haloperidol 2 mg did not
decrease craving also not consistent with a previous study
of Berger et al. (1996) who did find a decrease in cue-
elicited cocaine craving after a 4 mg doses of haloperidol. A
hypothetical explanation for this contrast may be that the 2
mg dose of haloperidol does induce a minimal decrease in
both attentional bias and craving. However, the minimal
change in attentional bias may be detected by sensitive RT-
paradigms, unlike the hypothetical decrease in craving,
which remains undetected by self-report. Further studies
using a higher dose of haloperidol should investigate this
hypothetical explanation. Although 2 mg haloperidol was
not able to reduce self-reported craving, it was able to
increase feelings of depression. This increase of depression
is a known side-effect of haloperidol (Ramaekers et al.,
1999). Another possibility is the status of the reliability of
self-reported craving. Taking the self-reported measures as
‘‘golden-standard’’ for investigating motivational construct
is at least ‘‘problematic’’ (Marissen et al., submitted for
publication; Miller, 1996; Sayette et al., 2000). In the later
study was found that self-reported heroin craving is ob-
scured by ‘‘social desirable’’ answering.
There were some limitations to the present study. First,
no healthy control group was used to compare with, only
within-group comparisons were made. However, a previous
studies using the same task did show that healthy controls
do not exhibit an attentional bias for heroin-related words
(Franken et al., 2000). Therefore, it is not likely that the
cognitive improvement would also be present in non-de-
pendent subjects. Second, the present sample-size is rather
small, more studies using larger sample-sized are needed.
Furthermore, it is not known why not all patients show the
haloperidol effect therefore, more research on the individual
differences should be conducted. Third, in the present study
we used the mixed version of the Stroop Task (heroin and
neutral words in mixed order). This obscured probably the
Stroop effect. Future studies may use blocked versions (first
all neutral words, then all heroin words) of the Stroop Task
which will probably result in larger differences. Fourth, we
did not have a record of the nicotine status of the partic-
ipants. However, it is reasonable to assume that their
nicotine status was not different between the two testing
conditions (placebo vs. haloperidol). Fifth, the data were
marginally significant. We employed additional non-para-
metric statistics (Wilcoxon signed ranks test) to test the
robustness of our findings. In the placebo condition, the
subjects had enhanced reaction times on the heroin cues
compared to the neutral cues (z= 2.296, P= 0.022). Thisindicates that heroin cues capture more attention than
neutral cues. However, in the haloperidol condition, no
difference was found between the reaction times on the
heroin cues compared to the neutral cues (z = 0.355,
P= 0.723). This indicates that in the haloperidol condition,
heroin cues do not capture more attention than neutral cues.
The findings of the non-parametric statistics underline our
original findings.
It would be premature to speculate about clinical impli-
cations of the present study. It is known that haloperidol
produces side-effects in neuroleptic naive subjects on higher
single dose admissions (Ramaekers et al., 1999) and also on
the longer term (Rosebush and Mazurek, 1999), which
decreases the usefulness of haloperidol in the treatment of
addictive behaviors. However, the present study provides
important clues on how dopamine is involved in human
addiction. It provides an indication that dopamine enhances
the attentional processing of drug cues in human heroin
abusers.Acknowledgements
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